Last Updated: August 10, 2026

List of Supplementary Protection Certificates

« Back to Dashboard

Biologic Drug Supplementary Protection Certificates

These international patent data are derived from patent families, based on US drug-patent linkages. Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Supplementary Protection Certificate	SPC Country	SPC Description	SPC Expiration
European Patent Office	2525812	283 14-2017	Slovakia	PRODUCT NAME: IDARUCIZUMAB; REGISTRATION NO/DATE: EU/1/15/1056 20151124	⤷ Start Trial
European Patent Office	2885007	122022000054	Germany	PRODUCT NAME: APEXXNAR - PNEUMOKOKKEN-POLYSACCHARID-SEROTYP 33F, KONJUGIERT AN DAS CRM197-TRAEGERPROTEIN DURCH EINEN (2-((2-OXOETHYL)THIO)ETHYL)CARBAMAT (ETEC)-SPACER; REGISTRATION NO/DATE: EU/1/21/1612 20220214	⤷ Start Trial
European Patent Office	2076541	122017000126	Germany	PRODUCT NAME: EIN ISOLIERTER ANTIKOERPER ODER EIN FRAGMENT DAVON, UMFASSEND CDR-SEQUENZEN DER LEICHTEN KETTE UND DER SCHWEREN KETTE NACH EP-B1-2076541 ANSPRUCH 1 (SEQ ID NOS: 224, 225, 226 UND 146, 147, 148), WOBEI DER ANTIKOERPER ODER DAS FRAGMENT DAVON HUMANEN IL-17 REZEPTOR A BINDET; INSBESONDERE EIN ANTIKOERPER, UMFASSEND DIE SEQUENZEN DER VARIABLEN REGION DER LEICHTEN UND SCHWEREN KETTE NACH EP-B1-2076541 ANS; REGISTRATION NO/DATE: EU/1/6/1155/001-002 20170717	⤷ Start Trial
European Patent Office	2504364	2019/002	Ireland	PRODUCT NAME: DURVALUMAB; REGISTRATION NO/DATE: EU/1/18/1322 20180921	⤷ Start Trial
European Patent Office	2059534	LUC00092	Luxembourg	PRODUCT NAME: TILDRAKIZUMAB; AUTHORISATION NUMBER AND DATE: EU/1/18/1323 20180919	⤷ Start Trial
European Patent Office	1957106	CA 2019 00026	Denmark	PRODUCT NAME: GALCANEZUMAB; REG. NO/DATE: EU/1/18/1330 20181116	⤷ Start Trial
>Country	>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Description	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.